NCT00028522View on ClinicalTrials.gov

R(+)XK469 in Treating Patients With Advanced Neuroblastoma

PHASE1CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

September 30, 2009

Conditions
Disseminated NeuroblastomaLocalized Unresectable NeuroblastomaRecurrent NeuroblastomaRegional Neuroblastoma
Interventions
DRUG

R(+)XK469

Given IV

Trial Locations (1)

60637-1470

University of Chicago Comprehensive Cancer Center, Chicago

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00028522 - R(+)XK469 in Treating Patients With Advanced Neuroblastoma | Biotech Hunter | Biotech Hunter